Cargando…

The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib

Cytokeratin 19-positive (CK19+) hepatocellular carcinoma (HCC) is an aggressive subtype characterized by early recurrence and chemotherapy tolerance. However, there is no specific therapeutic option for CK19+ HCC. The correlation between tumor recurrence and expression status of CK19 were studied in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuo, Jianyong, Lu, Di, Lin, Zuyuan, Yang, Xinyu, Yang, Modan, Wang, Jianguo, Tao, Yaoye, Wen, Xue, Li, Huihui, Lian, Zhengxing, Cen, Beini, Dong, Siyi, Wei, Xuyong, Xie, Haiyang, Zheng, Shusen, Shen, Youqing, Xu, Xiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595883/ https://www.ncbi.nlm.nih.gov/pubmed/34785656 http://dx.doi.org/10.1038/s41419-021-04320-4

Ejemplares similares

The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma
por: Lu, Di, et al.
Publicado: (2020)

Single‐cell profiling reveals distinct immune phenotypes that contribute to ischaemia‐reperfusion injury after steatotic liver transplantation
por: Yang, Xinyu, et al.
Publicado: (2021)

Molecular phenotypes reveal heterogeneous engraftments of patient-derived hepatocellular carcinoma xenografts
por: Zhuo, Jianyong, et al.
Publicado: (2021)

Metabolomic biomarkers for the diagnosis and post-transplant outcomes of AFP negative hepatocellular carcinoma
por: Lin, Zuyuan, et al.
Publicado: (2023)

The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases
por: Yang, Xinyu, et al.
Publicado: (2020)

Multi-omics profiling reveals Chitinase-3-like protein 1 as a key mediator in the crosstalk between sarcopenia and liver cancer
por: Lu, Di, et al.
Publicado: (2022)

Liver Organoids, Novel and Promising Modalities for Exploring and Repairing Liver Injury
por: He, Chiyu, et al.
Publicado: (2022)

Salinomycin-Loaded Small-Molecule Nanoprodrugs Enhance Anticancer Activity in Hepatocellular Carcinoma
por: Wang, Jianguo, et al.
Publicado: (2020)

Interleukin-2 inducible T-cell kinase: a potential prognostic biomarker and tumor microenvironment remodeling indicator for hepatocellular carcinoma
por: Pan, Binhua, et al.
Publicado: (2021)

Delivery of microRNA-33 Antagomirs by Mesoporous Silica Nanoparticles to Ameliorate Lipid Metabolic Disorders
por: Tao, Yaoye, et al.
Publicado: (2020)

MRI-Radiomics Prediction for Cytokeratin 19-Positive Hepatocellular Carcinoma: A Multicenter Study
por: Yang, Fan, et al.
Publicado: (2021)

High Expression of Human AugminComplex Submit 3 Indicates Poor Prognosis and Associates with Tumor Progression in Hepatocellular Carcinoma
por: Zhang, Xuanyu, et al.
Publicado: (2019)

A preoperative model for predicting microvascular invasion and assisting in prognostic stratification in liver transplantation for HCC regarding empirical criteria
por: Zhang, Wenhui, et al.
Publicado: (2021)

Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy
por: Xu, Shengjun, et al.
Publicado: (2021)

One Shoot, Two Birds: Alleviating Inflammation Caused by Ischemia/Reperfusion Injury to Reduce the Recurrence of Hepatocellular Carcinoma
por: Chen, Hao, et al.
Publicado: (2022)

Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1
por: Ling, Sunbin, et al.
Publicado: (2017)

Regorafenib induces Bim-mediated intrinsic apoptosis by blocking AKT-mediated FOXO3a nuclear export
por: Sun, Beini, et al.
Publicado: (2023)

The circFASN/miR-33a pathway participates in tacrolimus-induced dysregulation of hepatic triglyceride homeostasis
por: Zhang, Chenzhi, et al.
Publicado: (2020)

CR6-interacting factor 1 inhibits invasiveness by suppressing TGF-β-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
por: Zhuang, Runzhou, et al.
Publicado: (2017)

LEPREL1 Expression in Human Hepatocellular Carcinoma and Its Suppressor Role on Cell Proliferation
por: Wang, Jianguo, et al.
Publicado: (2013)

Characterization of genome-wide TFCP2 targets in hepatocellular carcinoma: implication of targets FN1 and TJP1 in metastasis
por: Xu, Xiao, et al.
Publicado: (2015)

Emerging and Innovative Theranostic Approaches for Mesoporous Silica Nanoparticles in Hepatocellular Carcinoma: Current Status and Advances
por: Tao, Yaoye, et al.
Publicado: (2020)

Stratified Analysis of Survival Benefit for ABO-incompatible Deceased-donor Liver Transplantation: Multicenter Propensity Score-matched Study
por: Yang, Mengfan, et al.
Publicado: (2023)

Experience with regorafenib in the treatment of hepatocellular carcinoma
por: Granito, Alessandro, et al.
Publicado: (2021)

Development of a Novel Prognostic Nomogram for High Model for End-Stage Liver Disease Score Recipients Following Deceased Donor Liver Transplantation
por: Yang, Mengfan, et al.
Publicado: (2022)

Diagnostic Value of Preoperative Needle Biopsy for Tumor Grading Assessment in Hepatocellular Carcinoma
por: Wang, Lijun, et al.
Publicado: (2015)

Cytokeratin 20-positive hepatocellular carcinoma
por: Fanni, D., et al.
Publicado: (2009)

Identification and Verification of a Novel MAGI2-AS3/miRNA-374-5p/FOXO1 Network Associated with HBV-Related HCC
por: Wang, Chao, et al.
Publicado: (2022)

miRNA profiles in livers with different mass deficits after partial hepatectomy and miR-106b~25 cluster accelerating hepatocyte proliferation in rats
por: Xu, Xiao, et al.
Publicado: (2016)

Proteomics‐based identification of the role of osteosarcoma amplified‐9 in hepatocellular carcinoma recurrence
por: Wei, Xuyong, et al.
Publicado: (2022)

Stem Cell Markers (Cytokeratin 17 and Cytokeratin 19) in Scarring and Nonscarring Alopecia
por: El Sakka, Dalia, et al.
Publicado: (2016)

The ongoing trends of patient‐derived xenograft models in oncology
por: Zhuo, Jianyong, et al.
Publicado: (2020)

A Contrast-Enhanced Computed Tomography Based Radiomics Approach for Preoperative Differentiation of Pancreatic Cystic Neoplasm Subtypes: A Feasibility Study
por: Shen, Xiaoyong, et al.
Publicado: (2020)

Clinical and molecular distinctions in patients with refractory colon cancer who benefit from regorafenib treatment
por: Lee, Min-Sang, et al.
Publicado: (2020)

Regorafenib in hepatocellular carcinoma: latest evidence and clinical implications
por: Personeni, Nicola, et al.
Publicado: (2018)

Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma
por: Kelley, Robin K., et al.
Publicado: (2020)

Cytokeratin phosphorylation, cytokeratin filament severing and the solubilization of the maternal mRNA Vg1
Publicado: (1991)

Identification of relevant prognostic values of cytokeratin 20 and cytokeratin 7 expressions in lung cancer
por: Luo, Hai-Tao, et al.
Publicado: (2017)

Evaluation of Cytokeratin-7 and Cytokeratin-19 Expression Relationship with Gleason Score in Prostatic Adenocarcinoma
por: Soltanipur, Masood, et al.
Publicado: (2023)

Erythema multiforme induced by regorafenib
por: Matsunaga, Mototsugu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ah0aqohdf5n104quq0pqc0stjk